Ligand-based prediction of hERG-mediated cardiotoxicity based on the integration of different machine learning

Pietro Delre1,2, Giovanna J Lavado3, Giuseppe Lamanna1,2

  • 1CNR-Institute of Crystallography, Bari, Italy.

Frontiers in Pharmacology
|September 22, 2022
PubMed

Insights

Predicting drug-induced cardiotoxicity is crucial for drug safety. This study developed highly predictive computational models for human ether-a-go-go-related (hERG) channel blockers using machine learning and curated chemical data.

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Toxicology

Background:

  • Drug-induced cardiotoxicity is a significant safety concern, often linked to off-target interactions with the cardiac hERG potassium channel.
  • Early identification of hERG channel blocking potential is essential in preclinical drug development to mitigate cardiotoxicity risks.

Purpose of the Study:

  • To develop and validate robust, ligand-based computational models for predicting hERG channel-mediated cardiotoxicity.
  • To establish a reliable computational workflow for assessing drug candidates' hERG blocking potential.

Main Methods:

  • Trained and validated 30 ligand-based classifiers using 7,963 compounds from the ChEMBL database (version 25).
  • Employed machine learning algorithms including random forest, k-nearest neighbors, gradient boosting, extreme gradient boosting, multilayer perceptron, and support vector machine.
  • Utilized best practices for data curation, VSURF for feature selection, and SMOTE for handling imbalanced data.

Main Results:

  • Achieved highly predictive models with maximal balanced accuracy (BA_MAX) of 0.91 and maximal area under the curve (AUC_MAX) of 0.95.
  • Temporal validation demonstrated the predictivity and superior performance of the developed classifiers compared to existing literature models.
  • A novel computational workflow for building predictive models of hERG-mediated cardiotoxicity was developed and made publicly available.

Conclusions:

  • The developed computational models and workflow provide a valuable tool for accurately predicting hERG-mediated cardiotoxicity in early drug discovery.
  • The study highlights the importance of rigorous data handling, feature selection, and imbalance management in building reliable predictive toxicology models.
  • The freely available computational workflow can aid researchers in prioritizing safer drug candidates and advancing drug discovery programs.